Align Technology (NASDAQ:ALGN – Free Report) had its target price raised by Leerink Partners from $225.00 to $230.00 in a research report report published on Thursday,MarketScreener reports. ALGN has been the topic of a number of other research reports. Robert W. Baird set a $218.00 price objective on Align Technology in a report on Thursday, […]

Seagate Technology (NASDAQ:STX – Free Report) had its price target lifted by Argus from $450.00 to $750.00 in a research note released on Thursday morning,MarketScreener reports. They currently have a buy rating on the data storage provider’s stock. STX has been the subject of a number of other research reports. Weiss Ratings reaffirmed a “buy […]

Marathon Digital (NASDAQ:MARA – Get Free Report) had its target price boosted by equities researchers at Rosenblatt Securities from $11.00 to $15.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the business services provider’s stock. Rosenblatt Securities’ price target suggests a potential upside of 25.10% from the […]

Viavi Solutions (NASDAQ:VIAV – Get Free Report) had its price objective lifted by equities research analysts at UBS Group from $25.00 to $60.00 in a report released on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the communications equipment provider’s stock. UBS Group’s target price suggests a potential upside of 14.50% from the […]

Ameris Bancorp (NASDAQ:ABCB – Get Free Report) had its target price raised by DA Davidson from $94.00 to $98.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the bank’s stock. DA Davidson’s target price would suggest a potential upside of 14.21% from the stock’s current price. ABCB […]

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) had its price objective lifted by equities researchers at Royal Bank Of Canada from $235.00 to $252.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank Of Canada’s price objective points to a potential […]

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its target price raised by equities researchers at Robert W. Baird from $7.00 to $13.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Robert W. Baird’s target price indicates a potential downside of 3.96% from the company’s previous […]

Intel (NASDAQ:INTC – Get Free Report) had its price objective upped by analysts at Bank of America from $48.00 to $56.00 in a research note issued on Friday,MarketScreener reports. The brokerage presently has an “underperform” rating on the chip maker’s stock. Bank of America‘s price target suggests a potential downside of 31.72% from the stock’s […]

Intel (NASDAQ:INTC – Get Free Report) had its target price raised by research analysts at Barclays from $45.00 to $65.00 in a research note issued to investors on Friday,MarketScreener reports. The firm currently has an “equal weight” rating on the chip maker’s stock. Barclays‘s price target points to a potential downside of 20.75% from the […]

Intel (NASDAQ:INTC – Get Free Report) had its target price raised by equities research analysts at Morgan Stanley from $56.00 to $73.00 in a report released on Friday,MarketScreener reports. The brokerage currently has an “equal weight” rating on the chip maker’s stock. Morgan Stanley’s target price would suggest a potential downside of 11.00% from the […]

Stock Yards Bancorp (NASDAQ:SYBT – Get Free Report) had its target price boosted by stock analysts at Stephens from $67.00 to $70.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the bank’s stock. Stephens’ price target points to a potential downside of 0.58% from […]

Zions Bancorporation, N.A. (NASDAQ:ZION – Get Free Report) had its target price hoisted by research analysts at Citigroup from $64.00 to $66.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the bank’s stock. Citigroup’s target price points to a potential upside of 6.74% from the company’s previous […]